open access
The Sisyphean task of VT mapping and ablation in structural heart disease


- Section of Cardiac Electrophysiology, Emory University Hospital, Atlanta, GA, United States
- Section of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
open access
Abstract
Abstract


Title
The Sisyphean task of VT mapping and ablation in structural heart disease
Journal
Kardiologia Polska (Polish Heart Journal)
Issue
Article type
Editorial
Published online
2023-01-27
Page views
25
Article views/downloads
28
DOI
10.33963/KP.a2023.0029
Authors
Michael Lloyd
Vardhmaan Jain


- Cronin E, Bogun F, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. EP Europace. 2019; 21(8): 1143–1144.
- Sapp JL, Wells GA, Parkash R, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016; 375(2): 111–121.
- Arenal Á, Ávila P, Jiménez-Candil J, et al. Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia. J Am Coll Cardiol. 2022; 79(15): 1441–1453.
- Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007; 357(26): 2657–2665.
- Karkowski G, Ząbek A, Szotek M, et al. et al.. Radiofrequency catheter ablation of ventricular tachycardia using combined endocardial techniques in patients with structural heart disease improves procedural effectiveness and reduces arrhythmia episodes. Kardiol Pol. 2022 [Epub ahead of print]: Dec.
- Sauer WH, Zado E, Gerstenfeld EP, et al. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm. 2010; 7(1): 9–14.